| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | mediator complex | 4.46e-05 | 37 | 39 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.62e-04 | 1377 | 39 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 5.09e-04 | 18 | 39 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | transcription regulator complex | 7.67e-04 | 596 | 39 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 1.59e-03 | 124 | 39 | 3 | GO:1904813 | |
| Domain | GST_C | 1.34e-03 | 26 | 39 | 2 | IPR004046 | |
| Domain | GST_C | 1.34e-03 | 26 | 39 | 2 | PF00043 | |
| Domain | Glutathione-S-Trfase_C-like | 3.00e-03 | 39 | 39 | 2 | IPR010987 | |
| Domain | - | 3.00e-03 | 39 | 39 | 2 | 1.20.1050.10 | |
| Domain | HMG_box | 5.47e-03 | 53 | 39 | 2 | PF00505 | |
| Domain | HMG_BOX_2 | 5.68e-03 | 54 | 39 | 2 | PS50118 | |
| Domain | HMG | 5.68e-03 | 54 | 39 | 2 | SM00398 | |
| Domain | - | 5.88e-03 | 55 | 39 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 8.13e-03 | 65 | 39 | 2 | IPR009071 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UNK EPRS1 EEF2 DDX46 RERE MARK2 RBBP6 CDK13 THRAP3 MED13 XRCC6 RRP12 | 3.06e-11 | 774 | 39 | 12 | 15302935 |
| Pubmed | 3.61e-08 | 655 | 39 | 9 | 35819319 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 EEF2 DDX46 MARK2 RBBP6 CDK13 THRAP3 USP6NL XRCC6 RRP12 | 6.77e-08 | 949 | 39 | 10 | 36574265 |
| Pubmed | SOX5 UNK MRPS18C RERE HSPA4L TAF1L RBBP6 XRCC6 STAT4 RRP12 YY2 | 3.14e-07 | 1429 | 39 | 11 | 35140242 | |
| Pubmed | UNK MRPS18C DDX46 MARK2 MED23 TAF1L RBBP6 CDK13 USP6NL MED13 RRP12 | 4.99e-07 | 1497 | 39 | 11 | 31527615 | |
| Pubmed | 5.94e-07 | 274 | 39 | 6 | 34244482 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 7.22e-07 | 678 | 39 | 8 | 30209976 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 8.70e-07 | 695 | 39 | 8 | 23602568 | |
| Pubmed | Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. | 8.77e-07 | 17 | 39 | 3 | 10235266 | |
| Pubmed | 1.31e-06 | 503 | 39 | 7 | 16964243 | ||
| Pubmed | 1.42e-06 | 1014 | 39 | 9 | 32416067 | ||
| Pubmed | 1.47e-06 | 20 | 39 | 3 | 15340084 | ||
| Pubmed | 1.98e-06 | 22 | 39 | 3 | 11867769 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 2.27e-06 | 23 | 39 | 3 | 10235267 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.64e-06 | 807 | 39 | 8 | 22681889 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.68e-06 | 220 | 39 | 5 | 35785414 | |
| Pubmed | 7.06e-06 | 421 | 39 | 6 | 34650049 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 9.00e-06 | 954 | 39 | 8 | 36373674 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.09e-05 | 262 | 39 | 5 | 36880596 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.19e-05 | 1318 | 39 | 9 | 30463901 | |
| Pubmed | 1.51e-05 | 731 | 39 | 7 | 29298432 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.58e-05 | 283 | 39 | 5 | 30585729 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.92e-05 | 759 | 39 | 7 | 35915203 | |
| Pubmed | 2.00e-05 | 506 | 39 | 6 | 30890647 | ||
| Pubmed | 2.07e-05 | 144 | 39 | 4 | 35681168 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 12093747 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.69e-05 | 154 | 39 | 4 | 16055720 | |
| Pubmed | A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis. | 3.42e-05 | 8 | 39 | 2 | 27579896 | |
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 10823961 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 28335007 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.42e-05 | 1149 | 39 | 8 | 35446349 | |
| Pubmed | 3.51e-05 | 1153 | 39 | 8 | 29845934 | ||
| Pubmed | Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. | 4.39e-05 | 9 | 39 | 2 | 12100890 | |
| Pubmed | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. | 4.39e-05 | 9 | 39 | 2 | 8710870 | |
| Pubmed | DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. | 4.39e-05 | 9 | 39 | 2 | 15678105 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 4.44e-05 | 175 | 39 | 4 | 25756610 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.74e-05 | 1203 | 39 | 8 | 29180619 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 27129234 | ||
| Pubmed | A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. | 5.48e-05 | 10 | 39 | 2 | 12218053 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 10037800 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 5.48e-05 | 10 | 39 | 2 | 23746844 | |
| Pubmed | 6.10e-05 | 1247 | 39 | 8 | 27684187 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 6.45e-05 | 1257 | 39 | 8 | 36526897 | |
| Pubmed | 7.75e-05 | 202 | 39 | 4 | 24639526 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 7.90e-05 | 1294 | 39 | 8 | 30804502 | |
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 11071752 | ||
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 7590241 | ||
| Pubmed | Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. | 8.03e-05 | 12 | 39 | 2 | 15749018 | |
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 19520787 | ||
| Pubmed | A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. | 9.48e-05 | 13 | 39 | 2 | 14657022 | |
| Pubmed | CDK8 is a positive regulator of transcriptional elongation within the serum response network. | 9.48e-05 | 13 | 39 | 2 | 20098423 | |
| Pubmed | Seven new members of the Sox gene family expressed during mouse development. | 9.48e-05 | 13 | 39 | 2 | 8441686 | |
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 12194848 | ||
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 27570068 | ||
| Pubmed | Cis-regulatory control of corticospinal system development and evolution. | 9.48e-05 | 13 | 39 | 2 | 22678282 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 9.49e-05 | 670 | 39 | 6 | 22990118 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.10e-04 | 221 | 39 | 4 | 29991511 | |
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 8921394 | ||
| Pubmed | Structure, function, and activator-induced conformations of the CRSP coactivator. | 1.11e-04 | 14 | 39 | 2 | 11834832 | |
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 34111398 | ||
| Pubmed | FOXG1 sequentially orchestrates subtype specification of postmitotic cortical projection neurons. | 1.11e-04 | 14 | 39 | 2 | 35613274 | |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.15e-04 | 224 | 39 | 4 | 28443643 | |
| Pubmed | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. | 1.17e-04 | 84 | 39 | 3 | 19135240 | |
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 18418385 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 1.27e-04 | 15 | 39 | 2 | 30871468 | |
| Pubmed | 1.28e-04 | 708 | 39 | 6 | 39231216 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.39e-04 | 235 | 39 | 4 | 30258100 | |
| Pubmed | 1.41e-04 | 236 | 39 | 4 | 36339263 | ||
| Pubmed | 1.43e-04 | 90 | 39 | 3 | 28978906 | ||
| Pubmed | 1.43e-04 | 237 | 39 | 4 | 29564676 | ||
| Pubmed | 1.44e-04 | 723 | 39 | 6 | 34133714 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 1.47e-04 | 1415 | 39 | 8 | 28515276 | |
| Pubmed | 1.48e-04 | 239 | 39 | 4 | 26641092 | ||
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 1.65e-04 | 17 | 39 | 2 | 27241892 | |
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 21779181 | ||
| Pubmed | 1.66e-04 | 1440 | 39 | 8 | 30833792 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.78e-04 | 1082 | 39 | 7 | 38697112 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.83e-04 | 475 | 39 | 5 | 31040226 | |
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 10198638 | ||
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 26864488 | ||
| Pubmed | 1.97e-04 | 483 | 39 | 5 | 36912080 | ||
| Pubmed | 2.00e-04 | 1103 | 39 | 7 | 34189442 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.03e-04 | 486 | 39 | 5 | 30940648 | |
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 2.07e-04 | 19 | 39 | 2 | 16799563 | |
| Pubmed | 2.07e-04 | 19 | 39 | 2 | 16204234 | ||
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 2.20e-04 | 104 | 39 | 3 | 36055981 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 2.39e-04 | 107 | 39 | 3 | 20508642 | |
| Pubmed | Expression of Sox transcription factors in the developing mouse pancreas. | 2.54e-04 | 21 | 39 | 2 | 12815626 | |
| Pubmed | 2.54e-04 | 21 | 39 | 2 | 27600842 | ||
| Pubmed | The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas. | 2.54e-04 | 21 | 39 | 2 | 16306355 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 2.75e-04 | 281 | 39 | 4 | 30455355 | |
| Pubmed | 2.79e-04 | 22 | 39 | 2 | 17084361 | ||
| Pubmed | 2.94e-04 | 286 | 39 | 4 | 32041737 | ||
| Pubmed | 3.00e-04 | 529 | 39 | 5 | 14621295 | ||
| Pubmed | 3.05e-04 | 23 | 39 | 2 | 30329130 | ||
| Pubmed | 3.43e-04 | 121 | 39 | 3 | 22412018 | ||
| Pubmed | 3.56e-04 | 549 | 39 | 5 | 38280479 | ||
| Pubmed | A cluster of three long-range enhancers directs regional Shh expression in the epithelial linings. | 3.62e-04 | 25 | 39 | 2 | 19369396 | |
| Pubmed | 3.91e-04 | 26 | 39 | 2 | 34506481 | ||
| Pubmed | 4.08e-04 | 878 | 39 | 6 | 37223481 | ||
| Interaction | RC3H2 interactions | 3.93e-06 | 667 | 39 | 9 | int:RC3H2 | |
| Interaction | RNF113A interactions | 5.30e-06 | 692 | 39 | 9 | int:RNF113A | |
| Interaction | MYCN interactions | FOXR1 EPRS1 MRPS18C EEF2 DDX46 MARK2 HSPA4L RBBP6 CDK13 THRAP3 XRCC6 RRP12 | 6.63e-06 | 1373 | 39 | 12 | int:MYCN |
| Interaction | HECTD1 interactions | 1.28e-05 | 984 | 39 | 10 | int:HECTD1 | |
| Interaction | TNIP1 interactions | UNK EPRS1 EEF2 DDX46 MARK2 RBBP6 CDK13 THRAP3 USP6NL XRCC6 RRP12 | 1.30e-05 | 1217 | 39 | 11 | int:TNIP1 |
| Interaction | HAPSTR1 interactions | 2.25e-05 | 829 | 39 | 9 | int:HAPSTR1 | |
| Interaction | ZNF608 interactions | 3.09e-05 | 93 | 39 | 4 | int:ZNF608 | |
| Interaction | GLDC interactions | 3.26e-05 | 321 | 39 | 6 | int:GLDC | |
| Interaction | SOX11 interactions | 1.01e-04 | 8 | 39 | 2 | int:SOX11 | |
| Interaction | ESRRB interactions | 1.43e-04 | 262 | 39 | 5 | int:ESRRB | |
| GeneFamily | SRY-boxes | 3.89e-04 | 19 | 28 | 2 | 757 | |
| GeneFamily | Cyclins|Mediator complex | 1.19e-03 | 33 | 28 | 2 | 1061 | |
| Coexpression | LI_WILMS_TUMOR_ANAPLASTIC_DN | 2.15e-05 | 5 | 39 | 2 | M1216 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.88e-05 | 610 | 39 | 7 | M3854 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.31e-05 | 650 | 39 | 7 | MM1042 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#4 | 2.22e-05 | 90 | 39 | 4 | Facebase_RNAseq_e8.5_Floor Plate_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.31e-05 | 339 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.96e-05 | 350 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.41e-05 | 118 | 39 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.30e-05 | 122 | 39 | 4 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.83e-04 | 893 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 2.67e-04 | 496 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 3.58e-04 | 986 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 3.65e-04 | 989 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.53e-07 | 190 | 39 | 5 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.80e-07 | 197 | 39 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-05 | 189 | 39 | 4 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 190 | 39 | 4 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.45e-05 | 194 | 39 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.60e-05 | 197 | 39 | 4 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| Disease | unipolar depression, bipolar disorder | 3.46e-05 | 156 | 35 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Glioblastoma Multiforme | 3.11e-04 | 111 | 35 | 3 | C1621958 | |
| Disease | sleep measurement | 5.51e-04 | 135 | 35 | 3 | EFO_0004870 | |
| Disease | Malignant neoplasm of salivary gland | 1.31e-03 | 45 | 35 | 2 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 1.43e-03 | 47 | 35 | 2 | C0036095 | |
| Disease | schizophrenia, anorexia nervosa | 1.49e-03 | 48 | 35 | 2 | MONDO_0005090, MONDO_0005351 | |
| Disease | obesity (implicated_via_orthology) | 2.10e-03 | 215 | 35 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | hearing threshold measurement, hearing measurement | 2.39e-03 | 61 | 35 | 2 | EFO_0007616, EFO_0007618 | |
| Disease | physical activity measurement | 3.04e-03 | 245 | 35 | 3 | EFO_0008002 | |
| Disease | susceptibility to strep throat measurement | 3.69e-03 | 76 | 35 | 2 | EFO_0008408 | |
| Disease | asthma, allergic disease | 3.98e-03 | 79 | 35 | 2 | MONDO_0004979, MONDO_0005271 | |
| Disease | systemic scleroderma | 4.59e-03 | 85 | 35 | 2 | EFO_0000717 | |
| Disease | cortical surface area measurement | 4.62e-03 | 1345 | 35 | 6 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPEDPKLKDGYYMRP | 361 | P49189 | |
| SKEPPSAYKEPPKAY | 286 | Q14004 | |
| PPKAYREDKTEPKAY | 296 | Q14004 | |
| LYKSKPGDDYEDPKD | 1146 | Q96MT7 | |
| LADQPKPVKEYKYPE | 491 | Q8TE57 | |
| KPVKEYKYPEKLPGE | 496 | Q8TE57 | |
| IGYKEKPQDVDLPYP | 36 | Q9Y243 | |
| YKEYPGGPKELDKSI | 486 | O95803 | |
| GAKDKGPEPTFKPYL | 706 | Q17RG1 | |
| DPAIPLLGIYPKDYK | 1171 | O00370 | |
| EYLDEAYPGKKLLPD | 91 | P78417 | |
| AYPGKKLLPDDPYEK | 96 | P78417 | |
| PLKGLLPYDKDLFEP | 251 | Q9ULK4 | |
| YPKPDVPKGYILDTD | 261 | Q9BXL5 | |
| EAYAIGKKEKPPFLP | 226 | Q7Z6E9 | |
| LEKKPNPDKDGPDYE | 36 | Q6PIV2 | |
| DELKPYVEPLPDYKD | 311 | Q7KZI7 | |
| PCPYDYIKIKVGPKV | 241 | P48740 | |
| GPNYTPGKKEDLYLK | 431 | P13639 | |
| TYFPPGKEPKEGERK | 971 | Q7L014 | |
| EPYVLFKKSDKPLYG | 441 | Q13002 | |
| ADYPDYKYRPRKKPK | 111 | P35716 | |
| YKEKTGQEYKPGNPP | 791 | P07814 | |
| NYYKRKPGKDPGAPD | 721 | Q8IZX4 | |
| FKKYGELPPIEKPVD | 536 | Q9P2R6 | |
| PKPSEIKDFSYVYKP | 891 | Q9UHV7 | |
| LLPERPPYLDKYEKF | 396 | Q9UJM3 | |
| PVTYKDPAYLKDPKV | 121 | Q9Y3D5 | |
| DVKKKGRPDPYAYIP | 1241 | Q5JTH9 | |
| QYPAGYPSDKEGKKP | 636 | Q96PU4 | |
| KELVYPPDYNPEGKV | 526 | P12956 | |
| LPEPGKEDEYPKKPL | 356 | Q92738 | |
| EPGYKAEGKYKDDPV | 701 | Q9Y2W1 | |
| KSYDSLYPPLAEPPK | 1521 | Q9C0A1 | |
| YGIYKQDLPPLDEKP | 181 | O95757 | |
| NPLKYLYPDIPKDKA | 656 | Q14765 | |
| NPPDYSEYLKGKKLP | 206 | O15391 | |
| YPDLELKYGPEKVSP | 76 | O75290 | |
| YPDLESKYGPEKISP | 76 | Q9Y6R6 | |
| GYEDEKKNEKPPKPS | 16 | Q6UX27 | |
| HLEKYPDYKYKPRPK | 616 | P35711 | |
| YVLGNYKTEPCKKPP | 211 | Q9C0B0 | |
| NLGPYEFKKETDKPP | 241 | Q9NWH7 |